NIH-funded research R01 grant

Dynamic nanoscale cellular imaging with time-resolved vitrification

Official title: Dynamic nanoscale cellular imaging via time-resolved cryo-vitrification

Funded at Harvard University · NIH-11413464 · Data updated 2026-11-12

A new tool called VERITAS will let scientists stimulate cells and then rapidly freeze them to see how tiny parts of the cell respond in real time.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard University
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 25, 2024
Project endJuly 31, 2028
Funding year2026
Award (this year)$349,625
NIH project number5R01GM154030-03
Project IDNIH-11413464 on NIH RePORTER

Who could benefit from this research

Could help

Not a patient-facing trial; primarily a technology development project. Applicable to human cells and clinical samples in future studies.

Less likely to help

No direct patient participation in this grant.

What this research studies

This grant aims to create a biophysical method that couples rapid chemical or biological stimulation of cells with millisecond-scale cryo-vitrification, enabling high-resolution study of dynamic cellular events. The approach links time-resolved freezing with advanced imaging to reveal membrane movements, protein interactions, and rapid biochemical changes. By providing a clearer picture of nanoscale processes as they unfold, the method could help researchers understand how cells respond to signals at the smallest scales. The project builds on prior technology and includes validation to ensure the technique produces reliable, interpretable data for broad use in cell biology.

Why it matters

Potential benefit: If successful, patients could benefit indirectly through faster discoveries about cellular mechanisms that underlie health and disease, potentially accelerating new therapies.

How similar studies have gone: Previous methods provide static snapshots; this project advances time-resolved imaging at the nanoscale, which is a novel capability with promising early signals.

Where this research is happening

  • Harvard University
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Prigozhin, Maxim — Harvard University
  • Study coordinator: Prigozhin, Maxim

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.